Published in J Neuropsychiatry Clin Neurosci on January 01, 1999
Frontal brain asymmetry in depression with comorbid anxiety: a neuropsychological investigation. J Abnorm Psychol (2012) 0.81
Cognitive performance in a subclinical obsessive-compulsive sample 1: cognitive functions. Psychiatry J (2013) 0.75
Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial. Crit Care Med (1996) 2.42
Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch Neurol (2001) 2.06
Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study. Neurology (2009) 1.77
When does human brain development end? Evidence of corpus callosum growth up to adulthood. Ann Neurol (1993) 1.62
Obsessive-compulsive symptoms in Parkinson's disease. J Neurol Neurosurg Psychiatry (2001) 1.47
Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. J Neurol Neurosurg Psychiatry (2006) 1.43
The role of prefrontal regions in the Stroop task. Neuropsychologia (1995) 1.39
Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry (2001) 1.26
Neuropsychological alterations in patients with computed tomography-detected basal ganglia calcification. Arch Neurol (1996) 1.20
Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia. Leukemia (2005) 1.19
Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioral measures. Arch Neurol (1997) 1.16
Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia. Br J Cancer (2004) 1.11
Reliability, validity, and classification accuracy of a Spanish translation of a measure of DSM-IV diagnostic criteria for pathological gambling. J Gambl Stud (2008) 1.10
Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry (2003) 1.09
Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Am J Psychiatry (2001) 1.08
The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. Laryngoscope (2001) 1.08
Neuropsychological findings in congenital and acquired childhood hydrocephalus. Neuropsychol Rev (2001) 1.08
Age effects on long-term neuropsychological outcome in paediatric traumatic brain injury. Brain Inj (2000) 1.06
An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol (1990) 1.06
Abnormal orbitofrontal development due to prematurity. Neurology (2006) 1.04
Cerebral correlates of declarative memory dysfunctions in early traumatic brain injury. J Neurol Neurosurg Psychiatry (2005) 1.03
Correlation of atrophy measures on MRI with neuropsychological sequelae in children and adolescents with traumatic brain injury. Brain Inj (2001) 1.00
Angiosarcoma variant of Kasabach-Merritt syndrome. Eur J Gastroenterol Hepatol (2001) 1.00
E1A3 as a unique, naturally occurring BCR-ABL transcript in an indolent case of chronic myeloid leukaemia. Br J Haematol (2001) 0.99
Differential features between bipolar I and bipolar II disorder. Compr Psychiatry (1997) 0.99
Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol (2007) 0.99
Long-term effects of bilateral frontal brain lesion: 60 years after injury with an iron bar. Arch Neurol (2001) 0.99
Panton-Valentine leukocidin-positive Staphylococcus aureus skin and soft tissue infections among children in an emergency department in Madrid, Spain. Clin Microbiol Infect (2010) 0.98
A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. Pharmacogenomics J (2007) 0.96
Suicide in patients treated for obsessive-compulsive disorder: a prospective follow-up study. J Affect Disord (2010) 0.95
Biological significance of iron-related magnetic resonance imaging changes in the brain. Arch Neurol (1992) 0.94
An in vivo model to study the anti-malaric capacity of plant extracts. Rev Biol Trop (1998) 0.92
Autoimmune cytopenias associated with malignancies and successfully treated with intravenous immune globulins: about two cases. Therapie (2000) 0.92
Neuropsychological long-term sequelae of perinatal asphyxia. Brain Inj (2001) 0.92
Structural correlates of facial emotion recognition deficits in Parkinson's disease patients. Neuropsychologia (2012) 0.90
Auditory event-related potentials in 50 melancholic patients: increased N100, N200 and P300 latencies and diminished P300 amplitude. J Affect Disord (2003) 0.90
Right hemisphere dysfunction in subjects with attention-deficit disorder with and without hyperactivity. J Child Neurol (1997) 0.90
MRI and genetic correlates of cognitive function in elders with memory impairment. Neurobiol Aging (2001) 0.90
Neuropsychological functioning in a subclinical obsessive-compulsive sample. Biol Psychiatry (1999) 0.90
Suicidal behavior in bipolar I and bipolar II disorder. J Nerv Ment Dis (1997) 0.89
Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome. Leukemia (2006) 0.89
Multiple memory deficits in patients with multiple sclerosis. Exploring the working memory system. Arch Neurol (1988) 0.89
The effect of medial frontal and posterior parietal demyelinating lesions on stroop interference. Neuroimage (2001) 0.89
Angiotensin I converting enzyme polymorphism in humans with age-associated memory impairment: relationship with cognitive performance. Neurosci Lett (2000) 0.89
Contribution of NTRK2 to the genetic susceptibility to anorexia nervosa, harm avoidance and minimum body mass index. Mol Psychiatry (2005) 0.89
Genetic susceptibility to obsessive-compulsive hoarding: the contribution of neurotrophic tyrosine kinase receptor type 3 gene. Genes Brain Behav (2008) 0.88
Effects of K+ channel blockers and openers on antinociception induced by agonists of 5-HT1A receptors. Eur J Pharmacol (1996) 0.88
Irreversible injury of cranial nerves 9 through 12 (Collet-Sicard syndrome). Case report. J Neurosurg (1973) 0.88
Anxiety disorders in the joint hypermobility syndrome. Psychiatry Res (1993) 0.88
Model-based prediction of nephropathia epidemica outbreaks based on climatological and vegetation data and bank vole population dynamics. Zoonoses Public Health (2012) 0.88
Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatology (1992) 0.87
[Neutralization of the hemorrhagic effect induced by Bothrops asper (Serpentes: Viperidae) venom with tropical plant extracts]. Rev Biol Trop (1999) 0.87
Arterial line filtration during cardiopulmonary bypass. Neurologic, neuropsychologic, and hematologic studies. J Thorac Cardiovasc Surg (1986) 0.87
Cognitive changes after cerebrospinal fluid shunting in young adults with spina bifida and assumed arrested hydrocephalus. J Neurol Neurosurg Psychiatry (2000) 0.86
Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims. Psychiatry Res (2000) 0.86
Treatment of refractory rapid cycling bipolar disorder with risperidone. J Clin Psychopharmacol (1998) 0.86
Prognostic value of changes in resting-state functional connectivity patterns in cognitive recovery after stroke: A 3T fMRI pilot study. Hum Brain Mapp (2014) 0.85
Apolipoproteins E and C1 and brain morphology in memory impaired elders. Neurogenetics (2002) 0.85
Subgroups among mu-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs. Br J Pharmacol (1995) 0.85
The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice. Psychopharmacology (Berl) (1996) 0.84
[Chemical and biological evaluation of the effect of plant extracts against Plasmodium berghei]. Rev Biol Trop (1996) 0.84
[Natural products from the tropical rain forest of Venezuela as inhibitors of HIV-1 replication]. Acta Cient Venez (1995) 0.83
Onset of antidepressant action: a pharmacological question? Hum Psychopharmacol (2005) 0.83
The normal epithelial cell-specific 1 (NES1) gene, a candidate tumor suppressor gene on chromosome 19q13.3-4, is downregulated by hypermethylation in acute lymphoblastic leukemia. Leukemia (2004) 0.83
MRI atrophy parameters related to cognitive and motor impairment in Parkinson's disease. Neurologia (2001) 0.83
Does reversed laterality really exist in dextrals? A case study. Neuropsychologia (1986) 0.83
Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder. Psychoneuroendocrinology (2010) 0.83
APOE and APOC1 genetic polymorphisms in age-associated memory impairment. Neurogenetics (2001) 0.82
Randomized clinical trial of the effect of intravenous fluid administration on hormonal and renal dysfunction in patients with obstructive jaundice undergoing endoscopic drainage. Br J Surg (2005) 0.82
Hypermethylation of the calcitonin gene in acute lymphoblastic leukaemia is associated with unfavourable clinical outcome. Br J Haematol (2001) 0.82
Comparative study of BCR-ABL1 quantification: Xpert assay, a feasible solution to standardization concerns. Ann Hematol (2012) 0.81
Do traditional executive measures tell us anything about daily-life functioning after traumatic brain injury in Spanish-speaking individuals? Brain Inj (2012) 0.81
Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors. J Pharmacol Exp Ther (1996) 0.81
Wallerian degeneration of the pyramidal tract in capsular infarction studied by magnetic resonance imaging. Stroke (1990) 0.81
Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients. J Affect Disord (1999) 0.80
[White matter changes and cognitive performance in aging]. Rev Neurol (2001) 0.80
Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease. Arch Neurol (1992) 0.80
In vitro suppression of HIV-1 replication by ajoene [(e)-(z)-4,5,9-trithiadodeca-1,6,11-triene-9 oxide]. Biomed Pharmacother (1997) 0.80
Colovesical fistula secondary to vesical gangrene in a diabetic patient. J Urol (1991) 0.80
[Functional magnetic resonance in the evaluation of the activity of the anterior cingulate cortex using Stroop's paradigm]. Rev Neurol (2002) 0.80
Effects of unilateral posteroventral pallidotomy on 'on-off' cognitive fluctuations in Parkinson's disease. Neuropsychologia (2000) 0.80
Hemispheric functional imbalance in a sub-clinical obsessive-compulsive sample assessed by the Continuous Performance Test, Identical Pairs version. Psychiatry Res (1997) 0.80
Schizophrenia and frontal cortex: where does it fail? Schizophr Res (2007) 0.79
Joint hypermobility syndrome and anxiety disorders. Lancet (1988) 0.79
Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b. Neurology (1999) 0.79
Frontal lobe activation during word generation studied by functional MRI. Acta Neurol Scand (1996) 0.79
Detection of genetic diversity among bovine immunodeficiency virus population by single-strand conformation polymorphism analysis. Viral Immunol (2000) 0.78
Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. J Clin Psychiatry (1987) 0.78
MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration? Neurology (1993) 0.78
Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain. J Neural Transm (Vienna) (1997) 0.78
(1)H-MR spectroscopy is sensitive to subtle effects of perinatal asphyxia. Neurology (2001) 0.78
[Attention deficit hyperactivity disorder. Cerebral asymmetry observed on magnetic resonance]. Rev Neurol (2000) 0.78